Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01704755
Brief Title: A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis (TURQUOISE-II)

First Submitted : September 28, 2012
First Submitted that Met QC Criteria : October 10, 2012
First Posted : October 11, 2012 (Estimate)

Results First Submitted : December 23, 2014
Results First Submitted that Met QC Criteria : December 23, 2014
Results First Posted : January 6, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 24, 2015
Last Update Posted : October 19, 2015 (Estimate)